Analysis of the relationship between the degree of dysbiosis in gut microbiota and prognosis at different stages of primary hepatocellular carcinoma

Frontiers in Microbiology

Volumn 10, Issue JUN, 2019, Pages

  Ni, Jiajia ^a   Huang, Rong ^b   Zhou, Huifang ^c   Xu, Xiaoping ^a   Li, Yang ^a   Cao, Peihua ^a   Zhong, Kebo ^a   Ge, Mei ^a   Chen, Xiaoxia ^a   Hou, Baohua ^d   Yu, Min ^d   Peng, Baogang ^e   Li, Qiao ^e   Zhang, Peng ^f   Gao, Yi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Southern Medical University ^*  (China)

^c First People's Hospital of Kashi   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chronic liver diseases; Dysbiosis degree; Gut microbiota; Primary hepatocellular carcinoma; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; RNA 16S;

ACTINOBACTERIA; ADULT; AKKERMANSIA; ARTICLE; BACTEROIDETES; BIFIDOBACTERIUM; BLAUTIA; BODY MASS; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DNA EXTRACTION; DYSBIOSIS; EURYARCHAEOTA; FECES MICROFLORA; FIRMICUTES; FUSOBACTERIA; HAEMOPHILUS; HELICOBACTER; HIGH THROUGHPUT SEQUENCING; HUMAN; INTESTINE FLORA; LACTOCOCCUS; LEPTOTRICHIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; POLYMERASE CHAIN REACTION; PREVOTELLA; PROTEOBACTERIA; ROSEBURIA; VEILLONELLA;

EID: 85069232946     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2019.01458     Document Type: Article

References (53)

1. Anderson, M. J. (2001). A new method for non-parametric multivariate analysis of variance. Austral. Ecol. 26, 32-46. doi: 10.1111/j.1442-9993.2001.01070.pp.x
2. Aron-Wisnewsky, J., Gaborit, B., Dutour, A., and Clement, K. (2013). Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin. Microbiol. Infect. 19, 338-348. doi: 10.1111/1469-0691.12140
3. Asnicar, F., Weingart, G., Tickle, T. L., Huttenhower, C., and Segata, N. (2015). Compact graphical representation of phylogenetic data and metadata with GraPhlAn. PeerJ 3:e1029. doi: 10.7717/peerj.1029
4. Aymeric, L., Donnadieu, F., Mulet, C., du Merle, L., Nigro, G., Saffarian, A., et al. (2018). Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization. Proc. Natl. Acad. Sci. U.S.A. 115, E283-E291. doi: 10.1073/pnas.1715112115
5. Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., et al. (2014a). Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment. Pharm. Therap. 39, 1113-1125. doi: 10.1111/apt.12695
6. Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., et al. (2014b). Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940-947. doi: 10.1016/j.jhep.2013.12.019
7. Bhattarai, Y., Pedrogo, D. A. M., and Kashyap, P. C. (2017). Irritable bowel syndrome: a gut microbiota-related disorder? Am. J. Physiol. Gastrointest. Liver Physiol. 312, G52-G62. doi: 10.1152/ajpgi.00338.2016
8. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336. doi: 10.1038/nmeth.f.303
9. Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., et al. (2016). Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115-132. doi: 10.3322/caac.21338
10. Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., et al. (2011). Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572. doi: 10.1002/hep.24423
11. Coker, O. O., Dai, Z., Nie, Y., Zhao, G., Cao, L., Nakatsu, G., et al. (2018). Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67, 1024-1032. doi: 10.1136/gutjnl-2017-314281
12. Darnaud, M., Faivre, J., and Moniaux, N. (2013). Targeting gut flora to prevent progression of hepatocellular carcinoma. J. Hepatol. 58, 385-387. doi: 10.1016/j.jhep.2012.08.019
13. Dixon, P. (2003). VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927-930. doi: 10.1111/j.1654-1103.2003.tb02228.x
14. Edgar, R. C. (2013). UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996-998. doi: 10.1038/NMETH.2604
15. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., and Knight, R. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200. doi: 10.1093/bioinformatics/btr381
16. El-Serag, H. B., and Kanwal, F. (2014). Epidemiology of hepatocellular carcinoma in the United States: where are we? where do we go? Hepatology 60, 1767-1775. doi: 10.1002/hep.27222
17. Fox, J. G., Feng, Y., Theve, E. J., Raczynski, A. R., Fiala, J. L. A., Doernte, A. L., et al. (2010). Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59, 88-97. doi: 10.1136/gut.2009.183749
18. Gao, Z., Buo, B., Gao, R., Zhu, Q., and Qin, H. (2015). Microbiota dysbiosis is associated with colorectal cancer. Front. Microbiol. 6:20. doi: 10.3389/fmicb.2015.00020
19. Gra.t, M., Ho.owko, W., Wronka, K. M., Gra.t, K., Lewandowski, Z., Kosi.ska, I., et al. (2015). The relevance of intestinal dysbiosis in liver transplant candidates. Transpl. Infect. Dis. 17, 174-184. doi: 10.1111/tid.12352
20. Grice, E. A., and Segre, J. A. (2013). The human microbiome: our second genome. Annu. Rev. Genomics Hum. Genet. 13, 151-170. doi: 10.1146/annurev-genom-090711-163814
21. Hegde, S., Lin, Y.-M., Golovko, G., Khanipov, K., Cong, Y., Savidge, T., et al. (2018). Microbiota dysbiosis and its pathophysiological significance in bowel obstruction. Sci. Rep. 8:13044. doi: 10.1038/s41598-018-31033-0
22. Houghton, D., Stewart, C. J., Day, C. P., and Trenell, M. (2016). Gut microbiota and lifestyle interventions in NAFLD. Int. J. Mol. Sci. 17:447. doi: 10.3390/ijms17040447
23. Huang, R., Li, T., Ni, J., Bai, X., Gao, Y., Li, Y., et al. (2018). Different sex-based responses of gut microbiota during the development of hepatocellular carcinoma in liver-specific Tsc1-knockout mice. Front. Microbiol. 9:1008. doi: 10.3389/fmicb.2018.01008
24. Huang, Y., Fan, X.-G., Wang, Z.-M., Zhou, J.-H., Tian, X.-F., and Li, N. (2004). Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J. Clin. Pathol. 57, 1273-1277. doi: 10.1136/jcp.2004.018556
25. Kamada, N., Chen, G. Y., Inohara, N., and Nunez, G. (2013). Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690. doi: 10.1038/ni.2608
26. Li, Z., Yu, E., Wang, G., Yu, D., Zhang, K., Gong, W., et al. (2018). Broad bean (Vicia faba L.) induces intestinal inflammation in grass carp (Ctenopharyngodon idellus C. et V) by increasing relative abundances of intestinal gram-negative and flagellated bacteria. Front. Microbiol. 9:1913. doi: 10.3389/fmicb.2018.01913
27. Lu, H., Wu, Z., Xu, W., Yang, J., Chen, Y., and Li, L. (2011). Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb. Ecol. 61, 693-703. doi: 10.1007/s00248-010-9801-8
28. Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., et al. (2018). Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 876:eaan5931. doi: 10.1126/science.aan5931
29. Magoc, T., and Salzberg, S. L. (2011). FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963. doi: 10.1093/bioinformatics/btr507
30. Malaguarnera, M., Gargante, M. P., and Malaguarnera, G. (2010). Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur. J. Gastroenterol. Hepatol. 22, 199-206. doi: 10.1097/MEG.0b013e328330a8d3
31. McGeoch, M. A. (2007). "Insects and bioindication: theory and progress, " in Insect Conservation Biology, eds A. J. A. Stewart, O. T. Lewis, and T. R. New (London: CABI Publishing), 144-174. doi: 10.1079/9781845932541.0144
32. Ni, J., Li, X., He, Z., and Xu, M. (2017). A novel method to determine the minimum number of sequences required for reliable microbial community analysis. J. Microbiol. Methods 139, 196-201. doi: 10.1016/j.mimet.2017.06.006
33. Oh, C. R. (2018). Correlation between dysbiosis of gut microbiota and human colorectal cancer. Int. Res. J. Adv. Eng. Sci. 3, 226-231.
34. Png, C. W., Linden, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., et al. (2010). Mucolytic bacteira with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420-2428. doi: 10.1038/ajg.2010.281
35. Quigley, E. M. M., Stanton, C., and Murphy, E. F. (2013). The gut microbiota and the liver. Pathophysiological and clinical implications. J. Hepatol. 58, 1020-1027. doi: 10.1016/j.jhep.2012.11.023
36. Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., et al. (2018). Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68, 1014-1023. doi: 10.1136/gutjnl-2017-315084
37. Schnabl, B. (2013). Linking intestinal homeostasis and liver disease. Curr. Opin. Gastroenterol. 29, 264-270. doi: 10.1097/mog.0b013e32835ff948
38. Shang, F., and Liu, H. (2018). Fusobacterium nucleatum and colorectal cancer: a review. World J. Gastrointest. Oncol. 10, 71-81. doi: 10.4251/wjgo.v10.i3.71
39. Shaw, K. A., Bertha, M., Hofmekler, T., Chopra, P., Vatanen, T., Srivatsa, A., et al. (2016). Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 8:75. doi: 10.1186/s13073-016-0331-y
40. Shen, F., Zheng, R. D., Sun, X. Q., Ding, W. J., Wang, X. Y., and Fan, J. G. (2017). Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobil. Pancreat. Dis. Int. 16, 375-381. doi: 10.1016/S1499-3872(17)60019-5
41. Shin, N.-R., Whon, T. W., and Bae, J.-W. (2015). Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33, 496-503. doi: 10.1016/j.tibtech.2015.06.011
42. Siegel, R. L., Miller, K. D., and Jemal, A. (2017). Cancer statistics, 2017. CA Cancer J. Clin. 67, 7-30. doi: 10.3322/caac.21387
43. Stecher, T., Normand, S., and Chamaillard, M. (2013). NOD2 prevents emergence of disease-predisposing microbiota. Gut Microb. 4, 353-356. doi: 10.4161/gmic.25275
44. Wang, Q., Garrity, G. M., Tiedje, J. M., and Cole, J. R. (2007). Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267. doi: 10.1128/aem.00062-07
45. Wong, V. W.-S., Tse, C.-H., Lam, T. T.-Y., Wong, G. L.-H., Chim, A. M.-L., Chu, W. C.-W., et al. (2013). Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis. a longitudinal study. PLoS One 8:e62885. doi: 10.1371/journal.pone.0062885
46. Xiang, J., He, T., Wang, P., Xie, M., Xiang, J., and Ni, J. (2018). Opportunistic pathogens are abundant in the gut of cultured giant spiny frog (Paa spinosa). Aquac. Res. 49, 2033-2041. doi: 10.1111/are.13660
47. Xie, G., Wang, X., Liu, P., Wei, R., Chen, W., Rajani, C., et al. (2016). Distinctly altered gut microbiota in the progression of liver disease. Oncotarget 7, 19355-19366. doi: 10.18632/oncotarget.8466
48. Ye, S. L. (2009). Expert consensus on standardization of the management of primary liver cancer. Chin. J. Hepatol. 17, 403-410. doi: 10.3781/j.issn.1000-7431.2009.04.001
49. Yu, L. X., and Schwabe, R. F. (2017). The gut microbiome and liver cancer: mechanisms and clinical translation. Nat. Rev. Gastroenterol. Hepatol. 14, 527-539. doi: 10.1038/nrgastro.2017.72
50. Yu, L. X., Yan, H. X., Liu, Q., Yang, W., Wu, H. P., Dong, W., et al. (2010). Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52, 1322-1333. doi: 10.1002/hep.23845
51. Zhang, H.-L., Yang, W., Tang, L., Lin, Y., Wu, H., et al. (2012). Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J. Hepatol. 57, 803-812. doi: 10.1016/j.jhep.2012.06.011
52. Zhou, J., Sun, H.-C., Wang, Z., Cong, W.-M., Wang, J.-H., Zeng, M.-S., et al. (2018). Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer 7, 235-260. doi: 10.1159/000488035
53. Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., et al. (2018). Personalized gut mucosal colonization resistance to Empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388-1405. doi: 10.1016/j.cell.2018.08.041